ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1377	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for ovarian, fallopian tube, and primary peritoneal cancers.	ovarian cancer incidence 0.485939 PLCO trial participants 0.376238 annual CA-125 concentrations 0.379685 control group 0.373899 TVU 0.416096 intervention group 0.456353 ovarian cancer mortality 0.605058 usual-care group 0.519997 ovarian cancer. 0.438341 simultaneous screening 0.374743 multimodality screening 0.410213 ovarian cancer patients 0.493657 Ovarian Cancer Screening 0.521015 multimodality screening arm 0.400746 term ovarian cancer 0.514244 ovarian screening intervention 0.52207 Ovarian cancer diagnoses 0.474885 positive screening test 0.421138 ovarian cancer 0.995711 ovarian origin 0.452276 screening group 0.412155 PLCO trial 0.50373 screening centers 0.380449 Single-threshold CA-125 levels 0.385265	CA-125 reference value 0.384378 multimodal screening 0.42795 women 0.438262 screening test results 0.415787 low-grade serous carcinomas. 0.372717 ovarian cancers 0.495247 mortality rate ratio 0.417901 CA-125 concentrations 0.454756 screening protocol 0.374983 CA-125 levels 0.452675 incident ovarian cancers 0.460255 concurrent bulky carcinomas 0.374346 annual screening 0.391284 statistically nonsignificant mortality 0.377585 regular screening attendees 0.399753 ovarian volume increases 0.454792 high-grade serous carcinoma 0.426123 Shizuoka Cancer Registry 0.385833 epithelial ovarian carcinomas. 0.474733 cancer case treatment 0.383697 single-threshold CA-125 concentrations 0.37905 stage 0.375125 Elevated CA-125 levels 0.386511 Cancer Screening Trial 0.444611	CLICK HERE
1471	National Cancer Institute	Html	en	Small Intestine Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of small intestine cancer.	illustrations 0.418999 duodenum. 0.42103 PDQ cancer information 0.903829 resectable leiomyosarcoma 0.536755 PDQ information 0.645092 Small intestine carcinomas 0.711426 multiple sites 0.521204 scientific images 0.511301 malignant lesions 0.542214 text 0.419438 cancer information summary 0.765692 National Institutes 0.515005 sentence 0.423056 breast cancer prevention 0.606867 author 0.434223 NCI’s PDQ 0.679179 PDQ Adult Treatment 0.75546 adenocarcinomas 0.421075 NCI PDQ cancer 0.783554 carcinoid tumors 0.53815 small intestine 0.82655 jejunum 0.420595 ileum 0.420633 relates 0.424246 resectable adenocarcinoma 0.544916	5-year survival rate 0.903147 common primary sarcoma 0.632045 content 0.419494 predominant modality 0.550555 literature 0.41999 overall 5-year survival 0.674093 National Cancer Institute 0.792644 trademark 0.418975 Editorial Board 0.520308 ability 0.4195 PDQ documents 0.647487 primary malignant tumors 0.647543 owner 0.419281 Visuals Online 0.515575 entirety 0.426542 Health 0.419895 cancer-related images 0.526463 permission 0.44717 NIH 0.422847 gastrointestinal malignancies 0.551608 resection 0.436749 duodenum 0.432045 policy statement 0.518223 independent review 0.515819	CLICK HERE
1567	National Cancer Institute	Html	en	Metastatic Squamous Neck Cancer with Occult Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic squamous neck cancer with occult primary.	cancer treatment 0.331255 neck muscles 0.258524 cancer spreads 0.287607 metastatic cancer 0.293108 malignant tumor cells 0.281382 body 0.321816 PDQ cancer information 0.347021 squamous cells 0.294186 clinical trial search 0.272504 external radiation treatment 0.262886 clinical trials 0.659393 cancer information summary 0.31748 clinical trial 0.463543 squamous cell cancer 0.363064 breast cancer prevention 0.264993 radical neck dissection 0.322726 patients 0.300058 earlier clinical trials 0.261657 treatment clinical trial 0.277097 PDQ Adult Treatment 0.268031 different types 0.294996 NCI PDQ cancer 0.286254 tests 0.272201 radiation therapy 0.490196 Treatment Editorial Board 0.283384	lung cancer cells 0.288937 currently used treatment 0.262475 metastatic squamous neck 0.988686 treatment 0.481959 Occult Primary Treatment 0.275159 new cancer treatments 0.27464 cancer cells 0.387801 Cancer Information Service 0.273937 PDQ Metastatic Squamous 0.312989 Hyperfractionated radiation therapy 0.272771 treatment clinical trials 0.300592 squamous neck cancer 0.954253 National Cancer Institute 0.34026 occult primary 0.527765 new treatment 0.321855 new treatments 0.258619 Cancer Care page 0.264657 primary tumor 0.396235 cancer research process 0.267043 cancer clinical trials 0.302055 treatment options 0.305059 cancer information summaries 0.272694 comprehensive cancer information 0.272807 occult primary tumor 0.271623	CLICK HERE
1679	National Cancer Institute	Html	en	Communication in Cancer Care (PDQ®)–Patient Version	It is important to talk to your doctor about your cancer diagnosis, goals of treatment, plan of care, and what to expect over time. Learn how good communication between patients, families, caregivers and doctors can improve the patient's quality of life in this expert-reviewed summary.	cancer treatment 0.389842 bad news 0.386292 questions 0.399361 PDQ cancer information 0.624305 health care team 0.981737 clinical trials 0.514782 Pediatric Supportive Care 0.404638 communication 0.486074 cancer information summary 0.515585 clinical trial 0.495706 family members 0.426143 cancer care 0.778281 breast cancer prevention 0.399685 PDQ summaries 0.394467 patients 0.573309 cancer patients 0.414288 team share information 0.427277 latest published information 0.403211 NCI’s PDQ 0.394236 PDQ summary Family 0.458483 NCI PDQ cancer 0.456705 supportive care 0.443184 treatment 0.599848 family caregivers 0.667411	cancer prevention 0.402033 Cancer Information Service 0.427003 Explain medical information 0.409499 PDQ Supportive 0.391221 patient 0.679815 PDQ Communication 0.403164 treatment clinical trials 0.401111 National Cancer Institute 0.597923 decisions 0.454448 PDQ documents 0.390179 Palliative Care Editorial 0.462952 medical information 0.462988 new treatment 0.398754 good communication 0.425774 Cancer Care page 0.429643 PDQ database 0.392979 Care Editorial Board 0.465833 PDQ summary 0.483184 doctor 0.450453 cancer clinical trials 0.415988 cancer information summaries 0.432334 comprehensive cancer information 0.43347 cancer patient 0.392432 cancer 0.840307	CLICK HERE
1760	National Cancer Institute	Html	en	Obesity and Cancer	A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and to cancer survivorship.	obesity causes cancer 0.394065 normal-weight people 0.279732 observational studies 0.323456 obesity prevalence 0.293137 obesity 0.638496 thyroid cancer risk 0.290632 obese people 0.350767 risk factors 0.298103 multiple myeloma 0.271306 colorectal cancer 0.326707 ovarian cancer 0.293192 body mass index 0.723663 prostate cancer risk 0.293391 postmenopausal breast cancer 0.29585 weight loss 0.380764 endometrial cancer increases 0.279353 cancer incidence data 0.260252 different cancer risk 0.325913 breast cancer survivors 0.303032 kidney cancer 0.323356 endometrial cancer 0.299756 invasive breast cancer 0.260923 menopausal hormone therapy 0.326286 women 0.298824 gallbladder cancer 0.347557	United States 0.307003 weight gain 0.259995 male breast cancer 0.288797 breast cancer diagnosis 0.278716 pancreatic cancer 0.309076 different cancer types 0.265661 LeRoith D. Obesity 0.262512 National Cancer Institute 0.329185 extremely obese women 0.271426 renal cell cancer 0.355343 increase cancer risk 0.312393 breast cancer risk 0.439989 breast cancer 0.64758 C. Gallbladder cancer 0.256715 cancer survivorship 0.270564 prostate cancer 0.294021 Breast Cancer WEight 0.309447 pancreatic cancer risk 0.295039 breast cancer pooling 0.266031 prospective studies 0.320099 et al 0.828361 cancer risk 0.662021 cancer 0.97959 liver cancer 0.398322	CLICK HERE
1816	National Cancer Institute	Html	es	Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.	gliomas highlights platelet-derived 0.0180248 encefálico infantiles recién 0.0174306 focal brainstem gliomas 0.0175295 brainstem tumors 0.0356739 mutación h3 k27m 0.0183362 activating acvr1 mutations 0.0269847 pediatric brain 0.0219051 glioma with 0.0184685 encefálico focales recidivantes 0.0176848 Radiat Oncol Biol 0.0940294 Pediatric Brain Tumor 0.0189297 mutación h3 0.0289221 diffuse brainstem glioma 0.0359565 brainstem gliomas 0.119063 central nervous system 0.0139993 recurrent activating acvr1 0.0274852 Nat Genet 0.0675122 intrinsic brain stem 0.0150908 patients with 0.025125 radiation therapy 0.0349088 intrinsic pontine glioma 0.946885 Acta Neuropathol 0.0426011 encefálico infantiles grupo 0.0167365 Broniscer A 0.0151338 intrinsic brainstem gliomas 0.0346829	Pediatric MATCH 0.0156687 encefálico focales recién 0.0279293 Neuro Oncol 0.0299682 with newly 0.0211799 brain stem gliomas 0.0552126 encefálico infantiles recidivantes 0.0293915 pediatric patients 0.0205505 low-grade glioma 0.0256326 Pediatr Blood Cancer 0.019874 intracranial low-grade gliomas 0.0165924 report from 0.0151672 tumores dipg 0.0243332 encefálico focales resección 0.0182395 Clin Oncol 0.0362551 Oncol Biol Phys 0.0989347 Zhou T 0.0230102 Neurosurg Pediatr 0.0180743 Pediatric Oncology Group 0.0173483 newly diagnosed 0.0303637 with neurofibromatosis 0.0165895 children's oncology group 0.138637 Acta Neuropathol Commun 0.0194776 Childs Nerv Syst 0.0434615 diffuse intrinsic pontine 0.990784	CLICK HERE
1921	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	almacena agua 0.377251 siguientes procedimientos 0.484494 Estadio IA 0.400496 estadio iv 0.835623 Estadio IC 0.400325 siguientes aspectos 0.39369 estadio ii 0.685519 Estadio IIIC 0.402008 estadios ia 0.349569 Estadio IIIA 0.403211 rayos x 0.363326 pulmón.ampliar cáncer 0.632928 menor cantidad 0.423989 luz solar 0.966967 Basal Cell Carcinoma 0.789488 vitamina d 0.373991 National Cancer Institute 0.332744	vitamina a 0.337818 siguientes riesgos 0.326866 pequeños carcinomas 0.336448 Instituto Nacional 0.361575 PDQ Tratamiento 0.358407 Drugs Approved 0.513635 Physician Data Query 0.424982 Cabello pelirrojo 0.519578 lápiz mide 0.408824 siguientes características 0.456672 cara.ampliar cirugía 0.345299 aspecto anormal.ampliar biopsia 0.448697 piel causa efectos 0.518422 panel derecho 0.432885 siguientes sumarios 0.432177 siguientes pruebas 0.387403	CLICK HERE
2075	National Cancer Institute	Html	es	Cánceres de cabeza y cuello	Hoja informativa acerca de los factores de riesgo, síntomas, diagnóstico, tratamiento, seguimiento y rehabilitación por los cánceres de cabeza y cuello.	Neck Cancer Epidemiology 0.358567 3rd ed 0.326841 NCI Vacunas 0.308043 American Cancer Society 0.337456 Epstein-Barr virus with 0.308914 Epstein-Barr virus 0.318034 Cancer Statistics 0.318768 Winn DM 0.308575 escamoso metastático 0.312489 case-control studies 0.308924 Cancer Institute State 0.321996 risk factors 0.312336 Brennan P 0.309874 Estados Unidos 0.32769 PubMed Abstract 0.972002 Gillison ML 0.308728 neck cancers 0.463711 Leclerc A 0.308319 patients with 0.31588 Cancer Epidemiology 0.478301 epstein-barr virus dna 0.30801 Boffetta P 0.327923 Chuang SC 0.308139 Cancer Epidemiology Consortium 0.352034 Cancer Journal 0.322016	International Journal 0.329442 Schottenfeld D 0.32536 upper aerodigestive tract 0.317554 second primary tumors 0.315336 United States 0.307873 neck squamous 0.307836 Fraumeni JF Jr 0.348613 International Head 0.313722 Nasopharyngeal Cancer 0.321339 occupational exposure 0.308922 National Cancer Institute 0.392376 Cancer Research 0.332513 Oxford University 0.322621 New York 0.321319 Yuan JM 0.308767 Epstein-Barr virus infection 0.308137 nasopharyngeal carcinoma 0.309899 international case-control study 0.316625 cáncer del nci 0.316951 Neck Surgery 0.30769 pooled analysis 0.329801 Clinical Cancer Research 0.320259 Habitual risk factors 0.308377 Cancer Biology 0.320747	CLICK HERE
15642	National Cancer Institute	Html	en	Introduction to the Grants Process	Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.	Grant section 0.330468 Grants Management Officer 0.557994 business management aspects 0.330645 Revision /Administrative Supplement 0.292103 ongoing extramural activity 0.334159 individual collaborates 0.230568 visit nci 0.417726 legally binding document 0.294148 grant type 0.376998 Application Development 0.390783 funding opportunity announcements 0.296925 particular grant program 0.476454 Research grant funds 0.454642 federal financial assistance 0.312865 scientific research projects 0.381722 additional history 0.228572 Name-Change Agreements 0.225495 cooperative agreement 0.324362 Federal funding limits 0.287544 cancer research services 0.337764 scientific aims 0.238931 recipient organizations 0.237533 NIH organizational component 0.335362 cooperative agreements 0.410646	scientific responsibility 0.224818 basic information 0.22908 Program Announcement 0.22809 clinical research 0.242867 grant application submissions 0.45483 Institutional Business Official 0.318274 grant award 0.34942 important process 0.252274 extramural scientists/clinicians 0.245811 grant application types 0.455543 recipient organization officials 0.350637 NCI Program Directors/Program 0.52301 Grants Management Specialists 0.412374 NCI Grants Management 0.594717 NCI grants process 0.906594 Program Announcements 0.289703 research organization 0.254758 Grants.gov Authorized Organizational 0.310309 cancer care delivery 0.312355 grant portfolio 0.3628 NCI grants program 0.607154 extramural program 0.270142 application process 0.236143 Recipient Institution/Organization 0.256421	CLICK HERE
16258	National Cancer Institute	Html	es	Exámenes de detección y detección temprana	El NCI apoya y dirige investigación sobre exámenes de detección y detección temprana de cáncer, incluyendo estudios para formular y validar marcadores biológicos.	Estados Unidos.  0.305194 cabo extensión 0.305776 Investigación Oncológica 0.305832 Mejor cuantificación 0.307132 amplia variedad 0.306584 Estados Unidos 0.358649 causarán síntomas 0.306983 cáncer colorrectal 0.434511 cabo análisis 0.306294 memorable estudio nacional 0.309583	sobretratamiento—el diagnóstico 0.307579 socioeconómicos específicos—que 0.307995 gente—con frecuencia 0.307545 cabo el NCI 0.307119 Mejor detección 0.335532 factores genéticos causantes 0.312309 El Programa Nacional Comunitario 0.309532 Nuevas tecnologías 0.306404 detección temprana 0.979153	CLICK HERE